Glaxosmithkline | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
AbbVie USD 1.46B 1.86B 2025-03
Amgen USD 7.43B 1.22B 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Aurora Cannabis CAD 588.68M 15.76M 2025-06
Bausch Health Companies USD 147M 1.33B 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Canopy Growth CAD 488.98M 102.49M 2025-06
Corcept Therapeutics USD 635.79M 47.49M 2025-06
Drreddys Laboratories INR 353.76B 36.03B 2025-06
Eli Lilly USD 18.27B 2.43B 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
Glaxosmithkline GBP 14.35B 683M 2025-06
J&J USD 78.11B 6.62B 2025-03
Merck USD 49.06B 725M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Pacira USD 757.77M 40.77M 2025-06
Perrigo USD 4.47B 108.3M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Prestige Brands USD 1.86B 20.58M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
Supernus Pharmaceuticals USD 1.06B 33.2M 2025-06
Takeda JPY 6.87T 69.82B 2025-06
Teva Pharmaceutical Industries USD 6.83B 572M 2025-06
Zoetis USD 4.98B 322M 2025-06


Glaxosmithkline Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.